Indivior to sell treatment rights to China's Zhejiang

Source: Dukascopy Bank SA
The drugmaker Indivior stated on Monday it was selling the rights tied with its Chinese opioid addiction treatment Sai Bo Song to the privately-owned Zhejiang Pukang Biotechnology for about $122.5M.
Back to articles

Actual Topics

Mon, 04 Feb 2019 10:36:09 GMT

Julius Baer to trim jobs amid poor profitability

Julius Baer is planning to trim up to 140 jobs, which is 2% of its workforce, on the back of the company's plan to cut costs announced this Monday, following a tough end of 2018.

Mon, 04 Feb 2019 09:18:19 GMT

Euronext likely to sweeten bid for Oslo Bors

On Monday, Euronext, the pan-EU stock market operator, stated it might sweeten its bid for Oslo Bors, as Nasdaq had made a rival proposal.

Subscribe to "Fundamental Analysis" feed

Subscribe
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.